$RDHL I am highly confident the Opaganib data on COVID will be positive. Redhill made public announcements when the final patient was enrolled as well as when the data collection was complete. It takes a few seconds once the code is broken to know the top line results. Since that point the company has highlighted studies about opaganib's efficacy on variants, as well as the decreased renal fibrosis data. If Opaganib doesn't have a positive effect, it would open up the company to shareholder lawsuits. The only question is how positive the data will be. I hope they are using all of this time to build a data summary (abstract) that puts Opaganib in the best possible light. You only get one chance to make a first impression and an oral covid treatment is medicine's Holy Grail - just ask Dr. Fauci.